Imunon, Inc.
IMNNDrugs in Pipeline
7
Phase 3 Programs
3
Upcoming Catalysts
1
Next Catalyst
Aug 30, 2026
24wMarket Overview
Stock performance and key metrics
1 upcoming, 0 past
ThermoDox
Hepatocellular Carcinoma
5% Dextrose Solution
Hepatocellular Carcinoma
IMNN-001 (IL-12 Plasmid Formulated with PEG-PEI-Cholesterol Lipopolymer)
Epithelial Ovarian Cancer
IMNN-001
Epithelial Ovarian Cancer
Paclitaxel
Ovarian Cancer
IMNN-101
SARS CoV 2 Infection
ThermoDox in combination with Microwave Hyperthermia (heat)
Breast Cancer
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
ThermoDox | Phase 3 | Hepatocellular Carcinoma | - | - |
5% Dextrose Solution | Phase 3 | Hepatocellular Carcinoma | - | - |
IMNN-001 (IL-12 Plasmid Formulated with PEG-PEI-Cholesterol Lipopolymer) | Phase 3 | Epithelial Ovarian Cancer | - | - |
IMNN-001 | Phase 2 | Epithelial Ovarian Cancer | - | - |
Paclitaxel | Phase 2 | Ovarian Cancer | - | - |
IMNN-101 | Phase 2 | SARS CoV 2 Infection | - | - |
ThermoDox in combination with Microwave Hyperthermia (heat) | Phase 2 | Breast Cancer | - | - |